These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 4077486

  • 21. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A, Despres JP, Clasey JL, Weltman JY, Wideman L, Kanaley J, Patrie J, Bergeron J, Thorner MO, Bouchard C, Hartman ML.
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [Abstract] [Full Text] [Related]

  • 22. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F, Maklady F, Saad M, el-Ashry M.
    Wien Klin Wochenschr; 1986 Apr 04; 98(7):209-11. PubMed ID: 3705598
    [Abstract] [Full Text] [Related]

  • 23. Postprandial plasma lipoproteins in normal and hypertriglyceridaemic subjects and their in vitro effect on platelet activity: differences between saturated and polyunsaturated fats.
    Aviram M, Fuhrman B, Brook JG.
    Scand J Clin Lab Invest; 1986 Oct 04; 46(6):571-9. PubMed ID: 3775243
    [Abstract] [Full Text] [Related]

  • 24. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S.
    Isr J Med Sci; 1976 Nov 04; 12(11):1261-8. PubMed ID: 1017927
    [Abstract] [Full Text] [Related]

  • 25. Arterial blood derived low density lipoprotein increases platelet aggregation and macrophage cholesterol content in comparison to lipoprotein derived from veinous blood.
    Keidar S, Aviram M, Grenadier E, Markiewicz W, Brook JG.
    Artery; 1989 Nov 04; 16(2):62-71. PubMed ID: 2496679
    [Abstract] [Full Text] [Related]

  • 26. [Alcohol-induced type V hyperlipidemia in relation to changes in the chemical composition of HDL2].
    Breier C, Lisch HJ, Braunsteiner H.
    Wien Klin Wochenschr; 1985 Mar 29; 97(7):316-9. PubMed ID: 3993040
    [Abstract] [Full Text] [Related]

  • 27. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
    Saniabadi AR, Umemura K, Shimoyama M, Adachi M, Nakano M, Nakashima M.
    Thromb Haemost; 1997 May 29; 77(5):996-1001. PubMed ID: 9184417
    [Abstract] [Full Text] [Related]

  • 28. [Hyperlipoproteinemia in primary gout and asymptomatic hyperuricemia].
    Kullich W, Ulreich A, Klein G.
    Wien Med Wochenschr; 1988 May 31; 138(10):221-5. PubMed ID: 3407202
    [Abstract] [Full Text] [Related]

  • 29. Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation.
    Viener A, Brook JG, Aviram M.
    Eur J Clin Invest; 1984 Jun 31; 14(3):207-13. PubMed ID: 6432549
    [Abstract] [Full Text] [Related]

  • 30. Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal.
    Desai K, Owen JS, Wilson DT, Hutton RA.
    Thromb Haemost; 1986 Apr 30; 55(2):173-7. PubMed ID: 3715785
    [Abstract] [Full Text] [Related]

  • 31. Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patients.
    Loschiavo C, Valvo E, Bedogna V, Casagrande P, Graziani MS, Nicoli M, Maschio G.
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov 30; 28(11):455-7. PubMed ID: 2272704
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I, Koller E, Li S, Yang Q, Banyai M, Rauscha F, Pidlich J, Pirker W, Sinzinger H.
    Atherosclerosis; 1993 Sep 30; 102(2):217-26. PubMed ID: 8251008
    [Abstract] [Full Text] [Related]

  • 34. Platelet function and serum high density lipoproteins.
    Nordøy A, Refsum N, Thelle D, Jaeger S.
    Thromb Haemost; 1979 Dec 21; 42(4):1181-6. PubMed ID: 232316
    [Abstract] [Full Text] [Related]

  • 35. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
    Aviram M, Furman B, Brook JG.
    Atherosclerosis; 1985 Aug 21; 56(2):157-67. PubMed ID: 4074453
    [Abstract] [Full Text] [Related]

  • 36. Role of apolipoproteins E and C in type V hyperlipoproteinemia.
    Kuusi T, Taskinen MR, Solakivi T, Kauppinen-Mäkelin R.
    J Lipid Res; 1988 Mar 21; 29(3):293-8. PubMed ID: 3379342
    [Abstract] [Full Text] [Related]

  • 37. [Amplification and inhibition of platelet function by serum lipoproteins].
    Higashihara M.
    Nihon Rinsho; 1992 Feb 21; 50(2):282-6. PubMed ID: 1613982
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Platelet function in a case with abetalipoproteinemia.
    Aviram M, Deckelbaum RJ, Brook JG.
    Atherosclerosis; 1985 Nov 21; 57(2-3):313-23. PubMed ID: 4084361
    [Abstract] [Full Text] [Related]

  • 40. Chylomicron-like particles in severe hypertriglyceridemia.
    Aviram M, Sechter Y, Brook JG.
    Lipids; 1985 Apr 21; 20(4):211-5. PubMed ID: 3999928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.